Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125273261 | 12527326 | 1 | I | 20160524 | 20160627 | 20160705 | 20160705 | PER | US-ASTRAZENECA-2016SE70795 | ASTRAZENECA | 23890.00 | DY | M | Y | 83.00000 | KG | 20160705 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125273261 | 12527326 | 1 | SS | LISINOPRIL. | LISINOPRIL | 1 | Oral | 18270 | MG | 0 | 10 | MG | TABLET | QD | |||||
| 125273261 | 12527326 | 2 | PS | BRILINTA | TICAGRELOR | 1 | Oral | 22433 | 90 | MG | TABLET | BID | |||||||
| 125273261 | 12527326 | 3 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 81 | MG | QD | ||||||||
| 125273261 | 12527326 | 4 | C | TYLENOL | ACETAMINOPHEN | 1 | Oral | 0 | 1000 | MG | QD | ||||||||
| 125273261 | 12527326 | 5 | C | EXCEDRIN | ACETAMINOPHENASPIRINCAFFEINE | 1 | Oral | 0 | 1000 | MG | QD | ||||||||
| 125273261 | 12527326 | 6 | C | TAMSULOSIN | TAMSULOSIN | 1 | Oral | 0 | .4 | MG | QD | ||||||||
| 125273261 | 12527326 | 7 | C | FENOFIBRATE. | FENOFIBRATE | 1 | Oral | 0 | 134 | MG | QD | ||||||||
| 125273261 | 12527326 | 8 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 0 | 40 | MG | QD | ||||||||
| 125273261 | 12527326 | 9 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 125273261 | 12527326 | 10 | C | IMITREX | SUMATRIPTAN SUCCINATE | 1 | Oral | 50.0MG UNKNOWN | 0 | 50 | MG | ||||||||
| 125273261 | 12527326 | 11 | C | NITROSTAT | NITROGLYCERIN | 1 | Unknown | 0.4MG UNKNOWN | 0 | .4 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125273261 | 12527326 | 1 | Blood pressure abnormal |
| 125273261 | 12527326 | 2 | Stent placement |
| 125273261 | 12527326 | 3 | Cardiac disorder |
| 125273261 | 12527326 | 4 | Migraine |
| 125273261 | 12527326 | 5 | Migraine |
| 125273261 | 12527326 | 6 | Prostate infection |
| 125273261 | 12527326 | 7 | Blood triglycerides abnormal |
| 125273261 | 12527326 | 8 | Blood cholesterol abnormal |
| 125273261 | 12527326 | 9 | Blood cholesterol abnormal |
| 125273261 | 12527326 | 10 | Migraine |
| 125273261 | 12527326 | 11 | Chest pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125273261 | 12527326 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125273261 | 12527326 | Dizziness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125273261 | 12527326 | 1 | 2011 | 0 | ||
| 125273261 | 12527326 | 2 | 201605 | 0 | ||
| 125273261 | 12527326 | 3 | 2012 | 0 | ||
| 125273261 | 12527326 | 4 | 201605 | 0 | ||
| 125273261 | 12527326 | 5 | 201605 | 0 | ||
| 125273261 | 12527326 | 6 | 201604 | 0 | ||
| 125273261 | 12527326 | 7 | 201604 | 0 | ||
| 125273261 | 12527326 | 8 | 201604 | 0 | ||
| 125273261 | 12527326 | 10 | 2001 | 0 | ||
| 125273261 | 12527326 | 11 | 201601 | 0 |